Search Results - "Tjønnfjord, Eirik Brekka"
-
1
Transformation to plasmablastic lymphoma in CLL upon ibrutinib treatment
Published in BMJ case reports (29-09-2020)“…Chronic lymphatic leukaemia (CLL) is the most common leukaemia in the Western world. Ibrutinib, a tyrosine kinase inhibitor, is the treatment of choice on…”
Get full text
Journal Article -
2
Successful Control of Hepatitis B Virus Reactivation following Restart of Ibrutinib in Chronic Lymphocytic Leukaemia
Published in Case reports in hematology (21-10-2021)“…Ibrutinib is a targeted therapy drug that blocks the activity of Bruton’s tyrosine kinase, and it is an approved treatment for several mature B-cell…”
Get full text
Journal Article -
3
Tyreotoksisk periodisk paralyse
Published in Tidsskrift for den Norske Lægeforening (20-08-2024)“…Thyrotoxic periodic paralysis is a rare and serious complication of hyperthyroidism.BackgroundThyrotoxic periodic paralysis is a rare and serious complication…”
Get full text
Journal Article -
4
New interest group for red blood cell disorders
Published in Tidsskrift for den Norske Lægeforening (21-02-2023)Get full text
Journal Article -
5
A woman in her fifties with cirrhosis of the liver and postural dyspnoea
Published in Tidsskrift for den Norske Lægeforening (10-10-2023)“…A woman in her fifties with advanced cirrhosis of the liver was admitted multiple times with recurrent pleural effusion and ascites. She was accepted for liver…”
Get full text
Journal Article -
6
Tyreotoksisk periodisk paralyse
Published in Tidsskrift for den Norske Lægeforening (30-04-2024)Get full text
Journal Article -
7
New interest group for red blood cell disorders
Published in Tidsskrift for den Norske Lægeforening (15-02-2023)Get full text
Journal Article -
8
A woman in her fifties with cirrhosis of the liver and postural dyspnoea
Published in Tidsskrift for den Norske Lægeforening (27-09-2023)Get full text
Journal Article -
9